Evidence map›Paper›PMID 28130301›Full record

ArticleApplied and environmental microbiology2017

Novel Aldo-Keto Reductases for the Biocatalytic Conversion of 3-Hydroxybutanal to 1,3-Butanediol: Structural and Biochemical Studies.

Taeho Kim, Robert Flick, Joseph Brunzelle, Alex Singer, Elena Evdokimova, Greg Brown, Jeong Chan Joo, George A Minasov, Wayne F Anderson, Radhakrishnan Mahadevan and 2 more

Abstract readComparative Study
In one paragraph

Article in Applied and environmental microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Discovery of a Cryptic Intermediate in Late Steps of Mithramycin Biosynthesis.Angewandte Chemie (International ed. in English) · 2020
    Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Taeho KimDepartment of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario, Canada.
Robert FlickDepartment of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario, Canada.
Joseph BrunzelleCenter for Structural Genomics of Infectious Diseases (CSGID), Department of Molecular Pharmacology and Biological Chemistry, Northwestern University, Chicago, Illinois, USA.
Alex SingerDepartment of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario, Canada.
Elena EvdokimovaDepartment of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario, Canada.
Greg BrownDepartment of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario, Canada.
Jeong Chan JooCenter for Biobased Chemistry, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea.
George A MinasovCenter for Structural Genomics of Infectious Diseases (CSGID), Department of Molecular Pharmacology and Biological Chemistry, Northwestern University, Chicago, Illinois, USA.
Wayne F AndersonCenter for Structural Genomics of Infectious Diseases (CSGID), Department of Molecular Pharmacology and Biological Chemistry, Northwestern University, Chicago, Illinois, USA.
Radhakrishnan MahadevanDepartment of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario, Canada.
Alexei SavchenkoDepartment of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario, Canada.
Alexander F YakuninDepartment of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario, Canada a.iakounine@utoronto.ca.

Funding

NIAID NIH HHS HHSN272200700058CNIAID NIH HHS HHSN272201200026C
6 · The paper itself

Abstract

The nonnatural alcohol 1,3-butanediol (1,3-BDO) is a valuable building block for the synthesis of various polymers. One of the potential pathways for the biosynthesis of 1,3-BDO includes the biotransformation of acetaldehyde to 1,3-BDO via 3-hydroxybutanal (3-HB) using aldolases and aldo-keto reductases (AKRs). This pathway requires an AKR selective for 3-HB, but inactive toward acetaldehyde, so it can be used for one-pot synthesis. In this work, we screened more than 20 purified uncharacterized AKRs for 3-HB reduction and identified 10 enzymes with significant activity and nine proteins with detectable activity. PA1127 from

Indexed as

Aldehyde ReductaseAldehydesBiocatalysisBiotechnologyButylene GlycolsCatalytic DomainCrystallizationMutagenesis, Site-DirectedNADPPseudomonas aeruginosaSalmonella typhimuriumSubstrate Specificity1,3-butylene glycol3-hydroxybutanalAldehyde ReductaseAldehydesButylene GlycolsNADP1,3-butanediolaldo-keto reductasebiocatalysisbiotechnologycrystal structuresite-directed mutagenesis

Identifiers

PMID28130301
PMCPMC5359500

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.